XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.1
STATEMENT OF CASH FLOWS - USD ($)
 4 Months Ended
Dec. 31, 2020
Dec. 31, 2020
Cash Flows from Operating Activities:    
Net Loss $ (12,971,424)  
Adjustments to reconcile net loss to net cash used in operating activities    
Change in fair value of derivative warrant liabilities 12,110,000  
Offering costs allocated to derivative warrant liabilities 749,253  
Payment of formation costs through issuance of Class B ordinary shares 5,000  
Interest earned on marketable securities held in Trust Account (1,973)  
Changes in operating assets and liabilities    
Prepaid expenses (237,088)  
Net cash used in operating activities (346,232)  
Cash Flows from Investing Activities:    
Investment of cash into Trust Account (232,300,000)  
Net cash used in investing activities (232,300,000)  
Cash Flows from Financing Activities    
Proceeds from sale of Units, net of underwriting discounts paid and reimbursements 226,150,000  
Proceeds from sale of Private Placement Warrants 8,900,000  
Repayment of promissory note - related party (124,826) $ (124,826)
Payment of offering costs (372,594)  
Net cash provided by financing activities 234,552,580  
Net increase in cash 1,906,348  
Cash - end of period 1,906,348 $ 1,906,348
Supplemental disclosure of noncash investing and financing activities:    
Initial classification of common stock subject to possible redemption 200,645,178  
Change in value of common stock subject to possible redemption (12,959,704)  
Warrant liabilities in connection with initial public offering and private placement 22,529,000  
Deferred underwriting fee payable 8,050,000  
Accrued offering costs 49,934  
Offering costs paid by Sponsor in exchange for Founder Shares 20,000  
Offering costs paid through Note payable $ 124,826